IDH1 and central nervous system cancer: In addition, in several cancer cells, an abnormally low NADPH/NADP+ ratio has been reported [56,57,58]; this suggests the recovery of cell reducing power as a primary necessity for tumor cells, often linked to IDH mutations frequently observed in glioma cells.